Author
Cochrane Neuraminidase Inhibitors Review TeamDel Mar, Chris
Doshi, Peter
Hama, Rokuro, M.D.
Heneghan, Carl
Jefferson, Tom
Jones, Mark A., B.Sc., Ph.D.
Thompson, Matthew J.
Date
2011-12-15Publisher
University of Chicago PressType
Article
Metadata
Show full item recordDescription
Letter to the Editor commenting on: Hernán MA, Lipsitch M. Oseltamivir and risk of lower respiratory tract complications in patients with flu symptoms: a meta-analysis of eleven randomized clinical trials. Clin Infect Dis. 2011 Available at: http://www.ncbi.nlm.nih.gov/pubmed/21677258. Accessed 30 June 2011. There is a reply by Hernán and Lipstich in Clinical Infectious Diseases, 2011 Dec 15; 53(12): 1303-1304. DOI: 10.1093/cid/cir717.Citation
Cochrane Neuraminidase Inhibitors Review Team. (2011). Does oseltamivir really reduce complications of influenza? Clinical Infectious Diseases, 53(12):1302-3. DOI: 10.1093/cid/cir706Sponsors
Grant support: 10/80/01/Department of Health/United Kingdom ; HTA/10/80/01/Department of Health/United KingdomKeyword
Antiviral Agents--administration & dosageHumans
Influenza, Human--complications
Influenza, Human--drug therapy
Oseltamivir--administration & dosage
Pneumonia, Bacterial--epidemiology
Pneumonia, Bacterial--prevention & control
Information Dissemination
Identifier to cite or link to this item
http://hdl.handle.net/10713/6668ae974a485f413a2113503eed53cd6c53
10.1093/cid/cir706